A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director – Global Compensation - Commercial

Compensation & BenefitsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$201.5k - $272.6k

About the Job

Requirements

  • At least 10 years of relevant compensation experience, with the ability to assess and evolve compensation and sales incentive plans, programs, policies, and processes for a growth-oriented biopharmaceutical company or similar fast-paced environment.
  • Experience advising, challenging, and influencing colleagues and building relationships at all organizational levels.
  • Experience supporting commercial organizations with the design, evaluation, or strategic consultation of compensation and incentive programs, including sales incentive plans.
  • Strong understanding of commercial compensation practices, including sales incentive principles, pay-for-performance philosophies, incentive governance, quota-based compensation structures, and market competitiveness.
  • Ability to analyze complex data and make informed recommendations.
  • Excellent written and verbal communication, attention to detail, and ability to build credibility with senior business leaders and translate complex compensation concepts into clear, actionable recommendations.
  • Ability to collaborate with partners and stakeholders across and outside Human Resources.
  • Advanced proficiency in Microsoft Excel.
  • Willingness to travel occasionally.

Responsibilities

  • Serve as the primary compensation business partner to the Global Commercial organization, partnering with Commercial leaders, Human Resources Business Partners, and Finance to provide strategic guidance on compensation programs, pay decisions, talent investments, market competitiveness, and strategies supporting business objectives and organizational growth.
  • Conduct market analyses, benchmarking, and compensation modeling to support hiring, retention, organizational design, and workforce planning across commercial functions.
  • Evaluate the effectiveness and competitiveness of compensation and sales incentive programs and recommend enhancements aligned with business outcomes.
  • Design, recommend, and implement data-driven compensation programs by evaluating market practices, trends, regulatory requirements, and costs to support competitive total rewards.
  • Provide strategic, consultative guidance to the business and Human Resources Business Partners on compensation matters, including salary management, sales incentive design, total rewards philosophy, programs, policies, job architecture, and support for strategic objectives.
  • Partner with Commercial Operations to provide expertise and strategic guidance on sales incentive plan design, performance measures, quota methodologies, payout governance, contests, and incentive effectiveness, ensuring programs are competitive, motivating, compliant, and aligned with business objectives.
  • Support the enhancement and evolution of compensation programs to align with the company’s lifecycle stage and educate employees on programs across global locations.
  • Develop executive-ready analyses, insights, and recommendations to support compensation decisions and leadership review processes.
  • Lead complex global compensation projects from conception through implementation, including project plans, timelines, stakeholder management, governance, communications, and change management activities.
  • Identify opportunities for process improvements and implement best practices to support programs.

Desired Qualifications

  • Experience supporting global compensation programs and partnering with business leaders across multiple geographies.
  • Working knowledge of equity compensation programs and their role in a broader total rewards strategy.
  • Experience supporting commercial organizations in biotechnology, pharmaceutical, medical device, or related life sciences industries.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs